THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION (ACCRF) SUPPORTS RESEARCH INTO ADENOID CYSTIC CARCINOMA THAT WILL ACCELERATE THE DEVELOPMENT OF IMPROVED THERAPIES AND A CURE FOR THE DISEASE.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$2.3M
-16.3% YoY
Annual Giving
$417K
+137.3% YoY
Grant Count
8
+100.0% YoY
Avg Grant Size
$52K
+18.6% YoY
About The Adenoid Cystic Carcinoma Research
Based on IRS filings
The Adenoid Cystic Carcinoma Research is a nonprofit organization focused on Medical Research, based in NEEDHAM, MA. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $2.3M in total assets. In 2024, it awarded 8 grants totaling $417K. Net investment income was $97K.
Focus Areas
Ready to take the next step with The Adenoid Cystic Carcinoma Research?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $2,251,893 | $2,690,770 | $2,659,707 |
| Revenue | $1,146,195 | $1,893,545 | $1,386,655 |
| Expenses | $1,458,198 | $1,872,720 | $1,618,196 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $96,890 | $90,836 | $27,583 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 8 recipients in 2024
Grant Size Distribution
34 grants across all recorded years
Open Grants
2 open opportunities from The Adenoid Cystic Carcinoma Research
Grant Opportunities (General Research Grants)
THE ADENOID CYSTIC CARCINOMA RESEARCH
Amount
$100,000 - $300,000 (typical; historic maximum $600,000)
Deadline
Rolling / Open
Kara Gelb Memorial Grant
THE ADENOID CYSTIC CARCINOMA RESEARCH
Amount
Varies
Deadline
Rolling / Open
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| JEFFREY A KAUFMAN | EXECUTIVE DIRECTOR/BOARD C | 50 | $150,000 |
| THOMAS DILENGE | BOARD VICE CHAIR | 5 | — |
| RALPH MOLLIS | TREASURER | 5 | — |
| MARNIE A KAUFMAN | DIRECTOR & CFO | 35 | — |
| ELIZABETH WEHLAGE | DIRECTOR | 5 | — |
| DAVID MORSE | DIRECTOR | 5 | — |
| BOZHO TODORICH | DIRECTOR | 5 | — |
| EMMA KINLOCH | DIRECTOR | 5 | — |
| NICOLE SPARDY BURR | DIRECTOR OF RESEARCH | 40 | $142,500 |
Subject Areas
Focus areas based on grantmaking activity
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with The Adenoid Cystic Carcinoma Research on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities